Anti-spasticity agents for multiple sclerosis.

  title={Anti-spasticity agents for multiple sclerosis.},
  author={David T Shakespeare and Mike Boggild and Carolyn A Young},
  journal={The Cochrane database of systematic reviews},
BACKGROUND Spasticity is a common problem in MS patients causing pain, spasms, loss of function and difficulties in nursing care. A variety of oral and parenteral medications are available. OBJECTIVES To assess the absolute and comparative efficacy and tolerability of anti-spasticity agents in multiple sclerosis (MS) patients. SEARCH STRATEGY We searched the Cochrane MS Group trials register (June 2003), the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 2, 2003), MEDLINE… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 92 extracted citations

Pharmacologic management of spasticity in multiple sclerosis

Neurological Sciences • 2006
View 10 Excerpts
Highly Influenced

Intrathecal baclofen pump for spasticity: an evidence-based analysis.

Ontario health technology assessment series • 2005
View 6 Excerpts
Highly Influenced

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

L. Lorente Fernándezb, E. Monte Boquetb, +5 authors B. Casanova-Estrucha
View 4 Excerpts
Highly Influenced

Intrathecal baclofen in multiple sclerosis: too little, too late?

Multiple sclerosis • 2011
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…